Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$6.99 - $9.26 $104,850 - $138,900
-15,000 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$8.49 - $19.54 $127,350 - $293,100
15,000 New
15,000 $127,000
Q2 2019

Aug 14, 2019

SELL
$22.93 - $42.84 $839,238 - $1.57 Million
-36,600 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$32.69 - $47.91 $1.2 Million - $1.75 Million
36,600 New
36,600 $1.42 Million

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $872M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.